BRKR - Bruker Corp
IEX Last Trade
67.18
-0.356 -0.530%
Share volume: 1,033,748
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$67.54
-0.36
-0.53%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-06 | 2022-08-05 | 2022-11-04 | 2023-03-01 | 2023-05-10 | 2023-08-09 | 2023-11-09 | 2024-02-29 | |
| Assets | |||||||||
| Total Assets | 3.551 B | 3.385 B | 3.337 B | 3.612 B | 3.764 B | 3.857 B | 3.820 B | 4.250 B | |
| Current Assets | 2.251 B | 2.088 B | 2.037 B | 2.113 B | 2.133 B | 2.183 B | 2.029 B | 2.164 B | |
| Inventories | 739.900 M | 759.000 M | 749.500 M | 800.100 M | 858.800 M | 914.600 M | 916.000 M | 968.300 M | |
| Other Current Assets | 181.000 M | 202.900 M | 239.600 M | 193.500 M | 204.600 M | 91.500 M | 93.600 M | 215.600 M | |
| Short Term Investments | 181.000 M | 202.900 M | 239.600 M | 193.500 M | 204.600 M | 91.500 M | 93.600 M | 215.600 M | |
| Total Receivables | 413.800 M | 402.600 M | 421.300 M | 472.700 M | 471.700 M | 602.400 M | 656.200 M | 492.000 M | |
| Current Cash | 916.100 M | 723.000 M | 626.200 M | 645.500 M | 597.900 M | 574.800 M | 363.600 M | 488.300 M | |
| Total Non-current Assets | 1.300 B | 1.297 B | 1.300 B | 1.499 B | 1.631 B | 1.674 B | 1.790 B | 2.086 B | |
| Property Plant Equipment | 403.800 M | 395.000 M | 421.500 M | 487.000 M | 510.900 M | 522.700 M | 527.000 M | 599.700 M | |
| Other Assets | 284.300 M | 272.600 M | 283.300 M | 155.100 M | 294.200 M | 292.700 M | 410.200 M | 184.000 M | |
| Intangible Assets | 227.500 M | 233.500 M | 214.000 M | 270.900 M | 298.500 M | 300.400 M | 291.900 M | 330.500 M | |
| Goodwill | 384.300 M | 396.200 M | 381.500 M | 457.600 M | 527.300 M | 557.900 M | 561.100 M | 582.600 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.551 B | 3.385 B | 3.337 B | 3.612 B | 3.764 B | 3.857 B | 3.820 B | 4.250 B | |
| Total liabilities | 2.534 B | 2.414 B | 2.400 B | 2.498 B | 2.584 B | 2.626 B | 2.611 B | 2.873 B | |
| Total current liabilities | 880.500 M | 818.400 M | 864.600 M | 914.300 M | 1.049 B | 1.051 B | 1.072 B | 1.202 B | |
| Accounts Payable | 161.200 M | 154.900 M | 157.700 M | 178.400 M | 196.200 M | 188.800 M | 181.500 M | 202.700 M | |
| Other liabilities | 426.700 M | 404.700 M | 381.800 M | 268.100 M | 395.600 M | 421.000 M | 404.500 M | 331.700 M | |
| Current long term debt | 11.000 M | 14.000 M | 17.000 M | 18.700 M | 120.100 M | 120.900 M | 121.000 M | 121.200 M | |
| Long term debt | 1.205 B | 1.171 B | 1.137 B | 1.201 B | 1.109 B | 1.123 B | 1.099 B | 1.160 B | |
| Other liabilities | 426.700 M | 404.700 M | 381.800 M | 268.100 M | 395.600 M | 421.000 M | 404.500 M | 331.700 M | |
| Minority interest | 21.100 M | 20.200 M | 16.700 M | 18.000 M | 30.500 M | 31.400 M | 35.400 M | 36.100 M | |
| Total Shareholder equity | 1.017 B | 970.500 M | 937.000 M | 1.114 B | 1.180 B | 1.231 B | 1.209 B | 1.377 B | |
| Common stock | 150.400 M | 149.000 M | 147.800 M | 147.200 M | 146.800 M | 146.800 M | 146.600 M | 145.400 M | |
| Retained earnings | 0.000 | 0.000 | 0.000 | 1.926 B | 1.995 B | 0.000 | 0.000 | 2.324 B |